As 2026 unfolds, the investment landscape is marked by significant movements in two distinct yet interconnected sectors: life sciences and the energy and compute infrastructure supporting artificial intelligence. Both are witnessing notable activity at the small- and mid-cap level, where understanding individual companies demands a depth of analysis beyond standard financial filings and stock charts. This environment underscores the relevance of the upcoming Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference, scheduled for September 9–10 at The Westin New York Grand Central.
The conference is designed to bring together these two sectors across two tracks and two days, providing investors with access to company presentations, panel discussions, and networking opportunities. By focusing on disruptive growth and life sciences, the event aims to address the unique challenges and opportunities present in these areas, where technological innovation and regulatory dynamics play pivotal roles. In the life sciences space, small and mid-cap companies are often at the forefront of breakthroughs in therapeutics, diagnostics, and medical devices, yet they face high development costs and lengthy approval processes. Meanwhile, the AI infrastructure sector encompasses companies involved in data centers, energy generation, and advanced computing hardware, which are essential to scaling artificial intelligence capabilities. These firms are navigating rapid demand growth, supply chain constraints, and the shift toward sustainable energy solutions.
The timing of the conference is particularly strategic. With both sectors experiencing heightened investor interest, the event offers a curated forum for due diligence and direct engagement with management teams. For investors, the ability to compare opportunities across these fields under one roof could prove invaluable, especially given the complexity and capital intensity inherent in these industries. The conference also reflects a broader trend where traditional sector boundaries are blurring, as life sciences increasingly rely on AI for drug discovery and data analysis, while AI infrastructure demands innovations in energy and materials that align with life sciences priorities.
Moody Capital Solutions, the host of the event, is leveraging its expertise to structure a program that addresses the most pressing questions facing investors today. Sessions are expected to cover topics such as financing strategies for emerging growth companies, regulatory landscapes, and the impact of macroeconomic factors on sector valuations. Attendees will have the chance to hear from industry experts and company executives who can provide insights into operational realities and future outlooks.
Registration for the conference is now open, and those interested can secure their spot by visiting the official event page at Moody Capital Conference Registration. As the market backdrop continues to evolve, this conference represents a timely opportunity for investors to gain a deeper understanding of two sectors that are poised to shape the economic landscape for years to come. Whether one is focused on the next biotech breakthrough or the infrastructure powering the AI revolution, the insights gathered here could be instrumental in making informed investment decisions.
